FAR Biotech, a computational drug discovery company using proprietary quantum modeling and deep learning AI to tackle high-impact diseases with significant unmet medical need, announced recently that it has moved from Houston to Forward BIOLABS.

“We’re thrilled to set up shop in Wisconsin and join the rapidly growing biohealth community, which we regard as highly complementary and supportive to FAR Biotech,” FAR Biotech Co-Founder and Director Max Duckworth said in a statement. “Wisconsin offers scientific excellence and pedigree, a collaborative and entrepreneurial culture, and a strategic, forward-looking mindset. With this move, FAR Biotech is not just opening an office in Madison–we’re committed to building and growing here.”

According to a release, the biotech company, which was founded in 2016, has been collaborating with the McArdle Laboratory for Cancer Research at the University of Wisconsin School of Medicine and Public Health and expects to work with additional Wisconsin researchers in the coming months.